Sentences with phrase «global dividend growth»

I like to complement great dividend growth stocks with one global dividend growth fund to ensure I'm diversified geographically.

A global dividend growth fund can help you diversify.

Global dividend growth faces two major headwinds in 2018 which could disrupt the otherwise - supportive backdrop for income, according to Martin Currie's Global Equity Income manager Mark Whitehead.»

There are a number of global dividend growth funds that have low expense ratios and have increased dividends over the past few years.

There are plenty of high - quality international dividend growth stocks that you can invest in without owning a global dividend growth fund.

I would not own a global dividend growth fund with those two stocks (BP and VOD) included in the top holdings.

Here is a strong list of ETFs that offer global dividend growth.

Here is a list of global dividend growth funds to choose from and their corresponding expense ratios:

If you are looking for international dividend exposure, look at global dividend growth funds to diversify your portfolio.

If you prefer to not invest in individual dividend growth stocks, you can build a dividend portfolio through global dividend growth funds.

We listed several global dividend growth funds with expense ratios less than 1 %.

In addition, we like the use of global dividend growth funds to diversify your retirement portfolio.

I sold the following two funds: RBC Canadian Equity Income Class A RBC Global Dividend Growth Class A

Not exact matches

Add in an average 3 % dividend, plus more global growth, and it may even break double digits.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

The Total Return approach used in our Global Equity Strategies emphasises the importance of dividend yield and dividend growth as well as price increases.

They offer fully managed accounts and also more specialized programs, such as their Thomas Partners dividend growth strategy and their Windhaven Strategies, which specializes in global diversification.

iShares S&P ® / TSX ® 60 Index Fund («XIU»), iShares S&P / TSX Capped Composite Index Fund («XIC»), iShares S&P / TSX Completion Index Fund («XMD»), iShares S&P / TSX SmallCap Index Fund («XCS»), iShares S&P / TSX Capped Energy Index Fund («XEG»), iShares S&P / TSX Capped Financials Index Fund («XFN»), iShares S&P / TSX Global Gold Index Fund («XGD»), iShares S&P / TSX Capped Information Technology Index Fund («XIT»), iShares S&P / TSX Capped REIT Index Fund («XRE»), iShares S&P / TSX Capped Materials Index Fund («XMA»), iShares Diversified Monthly Income Fund («XTR»), iShares S&P 500 Index Fund (CAD - Hedged)(«XSP»), iShares Jantzi Social Index Fund («XEN»), iShares Dow Jones Select Dividend Index Fund («XDV»), iShares Dow Jones Canada Select Growth Index Fund («XCG»), iShares Dow Jones Canada Select Value Index Fund («XCV»), iShares DEX Universe Bond Index Fund («XBB»), iShares DEX Short Term Bond Index Fund («XSB»), iShares DEX Real Return Bond Index Fund («XRB»), iShares DEX Long Term Bond Index Fund («XLB»), iShares DEX All Government Bond Index Fund («XGB»), and iShares DEX All Corporate Bond Index Fund («XCB»), iShares MSCI EAFE ® Index Fund (CAD - Hedged)(«XIN»), iShares Russell 2000 ® Index Fund (CAD - Hedged)(«XSU»), iShares Conservative Core Portfolio Builder Fund («XCR»), iShares Growth Core Portfolio Builder Fund («XGR»), iShares Global Completion Portfolio Builder Fund («XGC»), iShares Alternatives Completion Portfolio Builder Fund («XAL»), iShares MSCI Emerging Markets Index Fund («XEM») and iShares MSCI World Index Fund («XWD»), iShares MSCI Brazil Index Fund («XBZ»), iShares China Index Fund («XCH»), iShares S&P CNX Nifty India Index Fund («XID»), iShares S&P Latin America 40 Index Fund («XLA»), iShares U.S. High Yield Bond Index Fund (CAD - Hedged)(«XHY»), iShares U.S. IG Corporate Bond Index Fund (CAD - Hedged)(«XIG»), iShares DEX HYBrid Bond Index Fund («XHB»), iShares S&P / TSX North American Preferred Stock Index Fund (CAD - Hedged)(«XPF»), iShares S&P / TSX Equity Income Index Fund («XEI»), iShares S&P / TSX Capped Consumer Staples Index Fund («XST»), iShares Capped Utilities Index Fund («XUT»), iShares S&P / TSX Global Base Metals Index Fund («XBM»), iShares S&P Global Healthcare Index Fund (CAD - Hedged)(«XHC»), iShares NASDAQ 100 Index Fund (CAD - Hedged)(«XQQ») and iShares J.P. Morgan USD Emerging Markets Bond Index Fund (CAD - Hedged)(«XEB»)(collectively, the «Funds») may or may not be suitable for all investors.

We have two equity strategies: the North American dividend growth strategy, which can potentially invest in any company that trades in North America, and the global tactical ETF [exchange - traded fund] strategy, which uses a combination of exchange - traded funds to provide exposure around the globe.

Thanks to the power of compounding dividends and earnings growth, valuations of global developed stocks would need to fall by roughly 30 % over the next five years to generate negative returns for investors, our return assumptions suggest.

24/7 Wall St (N) The Aleph Blog (+) NFTRH (N) Bull Bear Trading Carl Futia (+) Dash of Insight (+) Dividend Growth Investor (+) Downside Hedge (+) Elliot Wave Lives On (+) Fallond Stock Picks (+) Global Economic Intersection -LRB--) GEI — Investing Blog -LRB--) Humble Student of the Markets (+) In the Money Learning Curve -LRB--) MaoXian MoneyShow.com Night Owl Trader -LRB--) Peridot Capitalist -LRB--) Prometheus Market Insight PUG Stock Market Analysis (+) Quant Investor (N) Shanky's Tech Blog -LRB--) Short Takes (N) Smart Money Tracker (N) Traders - Talk ValuePlays Wishing Wealth (+) Zentrader (+)

24/7 Wall St (N) The Aleph Blog (+) NFTRH (N) Bull Bear Trading Carl Futia Dash of Insight (+) Dividend Growth Investor (+) Downside Hedge (+) Elliot Wave Lives On (+) Fallond Stock Picks (N) Global Economic Intersection -LRB--) GEI — Investing Blog -LRB--) Humble Student of the Markets (+) In the Money Learning Curve -LRB--) MaoXian MoneyShow.com Night Owl Trader -LRB--) Peridot Capitalist -LRB--) Prometheus Market Insight -LRB--) PUG Stock Market Analysis (N) Quant Investor (N) Shanky's Tech Blog -LRB--) Short Takes (+) Smart Money Tracker (N) Traders - Talk (+) ValuePlays Wishing Wealth Zentrader (+) TheStockAdvisors.com

24/7 Wall St The Aleph Blog (+) NFTRH (N) Bull Bear Trading Carl Futia (+) Dash of Insight (+) Dividend Growth Investor (+) Downside Hedge (+) Elliot Wave Lives On (+) Fallond Stock Picks (+) Global Economic Intersection -LRB--) GEI — Investing Blog -LRB--) Humble Student of the Markets (+) In the Money Learning Curve -LRB--) MaoXian MoneyShow.com Night Owl Trader -LRB--) Peridot Capitalist -LRB--) Prometheus Market Insight PUG Stock Market Analysis (+) Quant Investor (N) Shanky's Tech Blog -LRB--) Short Takes (+) Smart Money Tracker (N) Traders - Talk ValuePlays Wishing Wealth (+) Zentrader (+)

24/7 Wall St (N) The Aleph Blog (+) NFTRH (N) Bull Bear Trading Carl Futia Dash of Insight (+) Dividend Growth Investor (+) Downside Hedge (N) Elliot Wave Lives On (+) Fallond Stock Picks -LRB--) Global Economic Intersection -LRB--) GEI — Investing Blog -LRB--) Humble Student of the Markets (+) In the Money Learning Curve -LRB--) MaoXian MoneyShow.com Night Owl Trader -LRB--) Peridot Capitalist -LRB--) Prometheus Market Insight PUG Stock Market Analysis (N) Quant Investor (N) Shanky's Tech Blog -LRB--) Short Takes (+) Smart Money Tracker (+) Traders - Talk ValuePlays Wishing Wealth (+) Zentrader (+) TheStockAdvisors.com

Now, as many investors worry about a global growth slowdown, rising rates and higher volatility in U.S. equity markets, dividend growers offer potential opportunities due to their healthy balance sheets, as well as better valuations, and lower volatility.

We like U.S. investment - grade credit, hard - currency EM debt, stocks in selected EMs and global quality and dividend growth stocks.

We think they're attractive because they have faster rising earnings, higher dividend yields and lower valuations than U.S. stocks, and they can benefit as global growth accelerates.

We see attractive dividend - growth opportunities in global pharmaceuticals, international telecom, emerging market (EM) infrastructure and selected information technology companies.

The following table presents links to in - depth analysis for ETFs tracking the Morningstar Global ex-US Dividend Growth Index.

The following table presents sortable tax data for ETFs currently tracking the Morningstar Global ex-US Dividend Growth Index.

ETFs tracking the Morningstar Global ex-US Dividend Growth Index are presented in the following table.

Thanks to the power of compounding dividends and earnings growth, valuations of global developed stocks would need to fall by roughly 30 % over the next five years to generate negative returns for investors, our return assumptions suggest.

The following table presents holdings data for all ETFs tracking the Morningstar Global ex-US Dividend Growth Index.

The following table presents dividend information for ETFs tracking the Morningstar Global ex-US Dividend Growth Index, including yield and dividedividend information for ETFs tracking the Morningstar Global ex-US Dividend Growth Index, including yield and divideDividend Growth Index, including yield and dividenddividend date.

The following table presents historical return data for ETFs tracking the Morningstar Global ex-US Dividend Growth Index.

We do see opportunities in emerging market companies, as well as in global firms with robust cash flows and dividend - growth potential.

The following table presents expense information for ETFs tracking the Morningstar Global ex-US Dividend Growth Index.

We do prefer stocks to government bonds, and within equities, we like global dividend - growth and quality stocks.

The fund had major equivalent positions in the Vanguard High Dividend Yield ETF (VYM), PowerShares Dynamic Large Cap Value Portfolio (PWV), First Trust Large Cap Growth AlphaDEX ® Fund (FTC), SPDR ® Barclays High Yield Bond ETF (JNK), SPDR ® S&P ® Homebuilders ETF (XHB), and iShares Global Consumer Staples ETF (KXI).

In addition to rewarding shareholders in the present with a healthy dividend payment, each of these companies is positioned to do well in the future as a result of global growth.

Position Disclosures: Dividend Portfolio Stocks — Long AAAMP Global Value Portfolio — None AAAMP Retirement Growth & Income Portfolio — Long AAAMP Treasure Trove Twelve Portfolio — Long

The fund had major equivalent positions in the iShares Global Consumer Discretionary ETF (RXI), Vanguard Dividend Appreciation ETF (VIG), Industrial Select Sector SPDR ® Fund (XLI), iShares MSCI Germany ETF (EWG), iShares Global Consumer Staples ETF (KXI), and iShares MSCI EAFE Growth ETF (EFG).

We see attractive dividend - growth opportunities in global pharmaceuticals, international telecom, emerging market (EM) infrastructure and selected information technology companies.

Now, as many investors worry about a global growth slowdown, rising rates and higher volatility in U.S. equity markets, dividend growers offer potential opportunities due to their healthy balance sheets, as well as better valuations, and lower volatility.

Guardian Capital is a global investor that believes quality dividend growth is a worthy proxy for corporate growth, and a critical element in picking stocks.

Position Disclosures: Dividend Portfolio Stocks — None AAAMP Global Value Portfolio — None AAAMP Dividend Growth & Income Portfolio — None AAAMP Treasure Trove Twelve Portfolio — Long

RBC Strategic Global Dividend Leaders ETF seeks to provide unitholders with exposure to the performance of a diversified portfolio of high - quality global dividend - paying equity securities that will provide regular income and that have the potential for long - term capital gGlobal Dividend Leaders ETF seeks to provide unitholders with exposure to the performance of a diversified portfolio of high - quality global dividend - paying equity securities that will provide regular income and that have the potential for long - term capitalDividend Leaders ETF seeks to provide unitholders with exposure to the performance of a diversified portfolio of high - quality global dividend - paying equity securities that will provide regular income and that have the potential for long - term capital gglobal dividend - paying equity securities that will provide regular income and that have the potential for long - term capitaldividend - paying equity securities that will provide regular income and that have the potential for long - term capital growth.

The development of a focused portfolio overlay applied to client accounts (according to timing and opportunities) covering 15 to 20 of our best ideas in global equities, targeting capital growth of 5 - 15 % and dividend income yield of 4 - 10 % (depending on market conditions).

Position Disclosures: Dividend Portfolio Stocks — None AAAMP Global Value Portfolio — None AAAMP Retirement Growth & Income Portfolio — None AAAMP Treasure Trove Twelve Portfolio — None

Position Disclosures: Dividend Portfolio Stocks — None AAAMP Global Value Portfolio — None AAAMP Dividend Growth & Income Portfolio — Long AAAMP Treasure Trove Twelve Portfolio — None